Tom Wilemon

December 6, 2018

Neuromodulation Society honors Hacker’s Parkinson’s research

Mallory Hacker, PhD, research assistant professor of Neurology, is the 2019 recipient of the Kumar New Investigator Award from the North American Neuromodulation Society.

By Tom Wilemon
November 15, 2018

New epilepsy monitoring systems collect better data

New epilepsy monitoring systems at Vanderbilt University Medical Center are providing neurologists better data for assessing adult and pediatric patients.

By Tom Wilemon
November 15, 2018

Immunotherapies linked to specific heart complications

In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis and arrhythmias, and that they occur early in the course of treatment.

By Tom Wilemon
November 8, 2018

Clinical fellows program bolstered by new NCI grant

A new grant from the National Cancer Institute (NCI) will fund an intensively mentored training experience for clinical fellows at Vanderbilt University Medical Center for the next five years.

By Tom Wilemon
November 8, 2018

Multi-factor authentication coming for C2HR users

Like employees the world over, Vanderbilt University Medical Center email system users are prey to frequent email spoofs, by which would-be identity thieves attempt to steal employee login credentials.

By Tom Wilemon
The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
November 2, 2018

Cancer Center among best in nation for stem cell transplant survival

Vanderbilt-Ingram Cancer Stem Cell Transplant ranks among the best in the nation for donor stem cell transplant survival rates among large centers, according to an annual report.

By Tom Wilemon
November 1, 2018

Warner’s medical informatics research recognized

Jeremy Warner, MD, is the 2018 recipient of the New Investigator Award from the American Medical Informatics Association (AMIA).
By Tom Wilemon
October 25, 2018

Mary Kay Foundation grant to bolster immunotherapy research

An immunotherapy research initiative at Vanderbilt University Medical Center is among those being supported by the Mary Kay Foundation, which has announced $1.2 million in funding that will be equally shared among 12 cancer research institutions.
By Tom Wilemon
October 25, 2018

Combination therapy improves small-cell lung cancer survival

Patients with stage IV small-cell lung cancer lived longer when given the immunotherapy atezolizumab with chemotherapy, setting the stage for what could become the first new treatment approved in decades for this particularly aggressive form of lung cancer.
By Tom Wilemon
October 18, 2018

Grant enhances study of new chemotherapy targets

Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.
By Tom Wilemon
October 11, 2018

Cancer Center investigators awarded Komen grants

Four Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.
By Tom Wilemon
October 4, 2018

VICC’s Levy to lead Rush University Cancer Center

Mia Levy, MD, PhD, director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC) and Ingram Associate Professor of Cancer Research, has been named director of Rush University Cancer Center and Systems Vice President for Cancer Service at Rush University Medical Center in Chicago.
By Tom Wilemon
1 … 21 22 23 24 25 … 34